Ann Arbor / Tokyo / Kyoto / Sarma / Technology / Sadhu / /
Company
Riobo N. A. / Pall Gelman Laboratory / Thermo Fisher Scientific / Takara / HP / Creative Commons / /
Country
Bangladesh / Japan / United States / / /
Facility
Howard Hughes Medical Institute / SuFu complex / Karolinska Institute / University of Salzburg / DNA complex / University of Dhaka / Khulna University / Chiba University / Ishibashi laboratory / GLI-DNA complex / /
IndustryTerm
residual proton chemical shift / natural products / ’ protocols / treatment of cancer / buffer solutions / /
MedicalCondition
smallcell lung cancer / basal-cell carcinomas / MS / cancers / cancer / tumors / DU145 cancer / /
Organization
Takeda Science Foundation / Hayashi Memorial Foundation for Female Natural Scientists / Naito Foundation / Chiba University / 1Graduate School of Pharmaceutical Sciences / Life Science School / Karolinska Institute / Khulna University / Khulna / Japan Society for the Promotion of Science / Beilstein-Institut / University of Salzburg / Howard Hughes Medical Institute / University of Dhaka / Dhaka / Tokyo Biochemical Research Foundation / Ministry of Education / /
Person
Midori A. Arai / Masami Ishibashi / Cycler Dice / Fritz Aberger / Hiroshi Sasaki / Gerhard Regl / Rune Toftgård / Bert Vogelstein / / /
Physalin H from Solanum nigrum as an Hh signaling inhibitor blocks GLI1–DNA-complex formation Midori A. Arai*1, Kyoko Uchida1, Samir K. Sadhu2, Firoj Ahmed3 and Masami Ishibashi*1 Full Research Paper